What is NDC 63323-351?

63323-351 is the product NDC for Rifampin, Rifampin 600 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Rifampin?

18 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Rifampin NDC 63323-351 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-351Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0351Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-351-20	6332303512063323035120	1 VIAL in 1 BOX (63323-351-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIALMarketed from Aug 21, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rifampin
Generic name (nonproprietary): rifampin
Active ingredients: Rifampin — 600 mg/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Fresenius Kabi USA, LLCNDC labeler code 63323
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091181
Marketing start: Aug 21, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Rifamycins (Chemical structure)
Identifiers: Product ID 63323-351_60eb9c46-3c34-455b-a740-c03884565072SPL ID 60eb9c46-3c34-455b-a740-c03884565072SPL set ID a1f9f1e2-dfc0-4d31-a13b-b656d897b791RxCUI 312821UNII VJT6J7R4TRUPC 0363323351205
Pharmacologic class: Rifamycin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323035120 followed by a unit qualifier and the quantity

Package 63323-0351-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 29, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampin and they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regim…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63323-351

What is NDC 63323-351?: 63323-351 is the product NDC for Rifampin, Rifampin 600 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Rifampin.
What is the active ingredient?: Rifampin.
Who is the labeler?: Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Rifampin?: 18 other product NDCs are listed under this name. See all Rifampin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Rifampin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Rifampin	Rifampin 150 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-892	70954-0892-1070954-0892-20
Rifampin	Rifampin 300 mg/1	CapsuleOral	ANI Pharmaceuticals, Inc.	70954-893	70954-0893-1070954-0893-2070954-0893-30
Rifampin	Rifampin 150 mg/1	CapsuleOral	Coupler LLC	67046-1605	67046-1605-03
rifampin	Rifampin 300 mg/1	CapsuleOral	Major Pharmaceuticals	0904-7315	00904-7315-61
Rifampin	Rifampin 150 mg/1	CapsuleOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-801	24658-0801-30
Rifampin	Rifampin 300 mg/1	CapsuleOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-802	24658-0802-60
Rifampin	Rifampin 300 mg/1	CapsuleOral	EPIC PHARMA, LLC	42806-799	42806-0799-0142806-0799-0542806-0799-30+1 more
Rifampin	Rifampin 150 mg/1	CapsuleOral	EPIC PHARMA, LLC	42806-801	42806-0801-0142806-0801-30
Rifampin	Rifampin 300 mg/1	CapsuleOral	American Health Packaging	60687-586	60687-0586-01
Rifampin	Rifampin 150 mg/1	CapsuleOral	American Health Packaging	60687-575	60687-0575-21

All 19 Rifampin NDCs